CSIMarket
 
Accelerate Diagnostics Inc   (NASDAQ: AXDX)
 

Accelerate Diagnostics Inc's Suppliers Performance

AXDX's Supply Chain




 
AXDX Costs vs Sales of Suppliers Growth Accelerate Diagnostics Inc's cost of sales deteriorated by -16.46 % year on year, relative to one quarter ago cost of sales fell by 0 % in Q4.

More on AXDX Suppliers



Accelerate Diagnostics Inc's cost of sales deteriorated by -16.46 % year on year, compare to one quarter ago cost of sales fell by 0 % in Q4.

More on AXDX Suppliers




Accelerate Diagnostics Inc's Comment on Supply Chain


The company procures various raw materials, including plastics, glass, metals, electronic and mechanical sub-assemblies, and biological and chemical products. It maintains multiple sourcing options and reviews suppliers for conflict minerals compliance. Certain components, particularly for the Accelerate Pheno system and the in-development Accelerate WAVE system, are sourced from sole suppliers. Despite cost increases driven by labor, supply disruptions, and inflation, the third-party manufacturing supply chain remains stable. The company holds sufficient inventory of Accelerate Pheno system instruments but experiences increased costs for components and raw materials used in Accelerate Pheno kits. Long-term sales agreements restrict the company's ability to pass these cost increases to customers. The company continuously monitors supplier capabilities and pursues alternative sources as necessary.

Accelerate Diagnostics Inc's Comment on Supply Chain


The company procures various raw materials, including plastics, glass, metals, electronic and mechanical sub-assemblies, and biological and chemical products. It maintains multiple sourcing options and reviews suppliers for conflict minerals compliance. Certain components, particularly for the Accelerate Pheno system and the in-development Accelerate WAVE system, are sourced from sole suppliers. Despite cost increases driven by labor, supply disruptions, and inflation, the third-party manufacturing supply chain remains stable. The company holds sufficient inventory of Accelerate Pheno system instruments but experiences increased costs for components and raw materials used in Accelerate Pheno kits. Long-term sales agreements restrict the company's ability to pass these cost increases to customers. The company continuously monitors supplier capabilities and pursues alternative sources as necessary.







AXDX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Accelerate Diagnostics Inc 0.79 11.07 -50.05 134
SUBTOTAL 0.00 0.00 0.00 -


Sources: Accelerate Diagnostics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Accelerate Diagnostics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.